COSMIN: Assessing the Methodological Quality of Measurement Instrument Studies

No. 'Adequate' rating is sufficient for most clinical applications. 'Very Good' rating is ideal but rare; many well-established, clinically useful instruments have historical validation studies with modest methodological detail. Look for convergence across multiple adequate studies rather than a single very good study.

Internal consistency (alpha) measures whether items within a scale correlate with each other (homogeneity); it is assessed from a single administration. Test-retest reliability measures whether scores are stable over time (typically 1–2 weeks without intervention); it requires two administrations. Both are important but measure different aspects of reliability.

Responsiveness is the instrument's ability to detect clinically meaningful change over time (e.g., improvement after treatment). An instrument can be highly valid at baseline yet have poor responsiveness (fail to reflect actual clinical improvement). Responsiveness is essential when the instrument will be used to monitor treatment effects or disease progression.

Not ideal, but context-dependent. If no alternative instruments exist, you may proceed with caution, noting the methodological limitations in your methods section. However, planning to conduct additional validation studies (e.g., responsiveness testing in your trial population) strengthens the evidence base. Consider contact with instrument developers.

Yes, if appropriate. COSMIN provides guidance on cross-cultural adaptation: translate, back-translate, cognitively test, and validate in the new population. Do not assume a well-validated English instrument is automatically valid in translated/cultural form; re-validation is recommended.